Cargando…
Effects of Bifidobacterium BL21 and Lacticaseibacillus LRa05 on gut microbiota in type 2 diabetes mellitus mice
Gut dysbiosis causes damage to the intestinal barrier and is associated with type 2 diabetes mellitus (T2DM). We tested the potential protective effects of probiotic BL21 and LRa05 on gut microbiota in type 2 diabetes mellitus mice and determined whether these effects were related to the modulation...
Autores principales: | Gai, Zhonghui, Liao, Wenyan, Huang, Yue, Dong, Yao, Feng, Huafeng, Han, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505128/ https://www.ncbi.nlm.nih.gov/pubmed/37716924 http://dx.doi.org/10.1186/s13568-023-01603-1 |
Ejemplares similares
-
Changes in the gut microbiota composition of healthy young volunteers after administration of Lacticaseibacillus rhamnosus LRa05: A placebo-controlled study
por: Gai, Zhonghui, et al.
Publicado: (2023) -
Bifidobacterium BLa80 mitigates colitis by altering gut microbiota and alleviating inflammation
por: Dong, Yao, et al.
Publicado: (2022) -
Lacticaseibacillus rhamnosus Hao9 exerts antidiabetic effects by regulating gut microbiome, glucagon metabolism, and insulin levels in type 2 diabetic mice
por: Han, Mei, et al.
Publicado: (2023) -
Effects of Synbiotic Lacticaseibacillus paracasei, Bifidobacterium breve, and Prebiotics on the Growth Stimulation of Beneficial Gut Microbiota
por: Kaewarsar, Ekkachai, et al.
Publicado: (2023) -
Safety Evaluation of Bifidobacterium lactis BL-99 and Lacticaseibacillus paracasei K56 and ET-22 in vitro and in vivo
por: Lu, Hongyun, et al.
Publicado: (2021)